{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:07:20Z","timestamp":1780384040704,"version":"3.54.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The aim of our study was to explore and evaluate the relationship between insulin resistance and progression of coronary atherosclerotic plaques. With the great burden coronary heart disease is imposing on individuals, healthcare professionals have already embarked on determining its potential modifiable risk factors in the light of preventive medicine. Insulin resistance has been generally recognized as a novel risk factor based on epidemiological studies; however, few researches have focused on its effect on coronary atherosclerotic plaque progression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>From June 7, 2007 to December 30, 2011, 366 patients received their index coronary angiogram and were subsequently found to have coronary atherosclerotic plaques or normal angiograms were consecutively enrolled in the study by the department of cardiology at the Ruijin Hospital, which is affiliated to the Shanghai Jiaotong University School of Medicine. All patients had follow-up angiograms after the 1-year period for evaluating the progression of the coronary lesions. The modified Gensini score was adopted for assessing coronary lesions while the HOMA-IR method was utilized for determining the state of their insulin resistance. Baseline characteristics and laboratory test results were described and the binomial regression analysis was conducted to investigate the relationship between insulin resistance and coronary atherosclerotic plaque progression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Index and follow-up Gensini scores were similar between the higher insulin lower insulin resistant groups (9.09\u2009\u00b1\u200914.33 vs 9.44\u2009\u00b1\u200912.88, <jats:italic>p<\/jats:italic>\u2009=\u20090.813 and 17.21\u2009\u00b1\u200918.46 vs 14.09\u2009\u00b1\u200914.18, <jats:italic>p<\/jats:italic> =0.358). However the Gensini score assessing coronary lesion progression between both visits was significantly elevated in the higher insulin resistant group (8.13\u2009\u00b1\u200911.83 versus 4.65\u2009\u00b1\u20097.58, <jats:italic>p<\/jats:italic>\u2009=\u20090.019). Multivariate logistic binomial regression analysis revealed that insulin resistance (HOMA-IR\u2009&gt;\u20093.4583) was an independent predictor for coronary arterial plaque progression (OR\u2009=\u20094.969, <jats:italic>p<\/jats:italic>\u2009=\u20090.011). We also divided all the participants into a diabetic (n\u2009=\u2009136) and a non-diabetic group (n\u2009=\u2009230), and HOMA-IR remained an independent predictor for atherosclerosis plaque progression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Insulin resistance is an independent predictor of atherosclerosis plaque progression in patients with coronary heart disease in both the diabetic and non-diabetic population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1475-2840-11-71","type":"journal-article","created":{"date-parts":[[2012,6,25]],"date-time":"2012-06-25T14:17:08Z","timestamp":1340633828000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Insulin resistance predicts progression of de novo atherosclerotic plaques in patients with coronary heart disease: a one-year follow-up study"],"prefix":"10.1186","volume":"11","author":[{"given":"Xuanqi","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinzhou","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Run","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,6,18]]},"reference":[{"key":"500_CR1","first-page":"325","volume":"5","author":"K Richard","year":"2011","unstructured":"Richard K: Primary prevention of coronary heart disease. Drug Des Devel Ther. 2011, 5: 325-380.","journal-title":"Drug Des Devel Ther"},{"key":"500_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/1753944710391350","volume":"5","author":"K Richard","year":"2011","unstructured":"Richard K: Is prevention a fantasy, or the future of medicine? A panoramic view of recent data, status, and direction in cardiovascular prevention. Ther Adv Cardiovasc Dis. 2011, 5: 61-81. 10.1177\/1753944710391350.","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"500_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1210\/er.2007-0006","volume":"28","author":"R Muniyappa","year":"2007","unstructured":"Muniyappa R, Montagnani M, Koh KK, Quon MJ: Cardiovascular actions of insulin. Endocr Rev. 2007, 28: 463-491. 10.1210\/er.2007-0006.","journal-title":"Endocr Rev"},{"key":"500_CR4","first-page":"201","volume":"47","author":"GM Reaven","year":"2005","unstructured":"Reaven GM: Insulin resistance, the insulin resistance syndrome, and cardiovascular disease. Panminerva Med. 2005, 47: 201-210.","journal-title":"Panminerva Med"},{"key":"500_CR5","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","volume":"113","author":"JA Kim","year":"2006","unstructured":"Kim JA, Montagnani M, Koh KK, Quon MJ: Reciprocal relationships between insulin resistance and endothelial dysfunction molecular and pathophysiological mechanisms. Circulation. 2006, 113: 1888-1904. 10.1161\/CIRCULATIONAHA.105.563213.","journal-title":"Circulation"},{"key":"500_CR6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and h-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia. 1985, 28: 412-419. 10.1007\/BF00280883.","journal-title":"Diabetologia"},{"key":"500_CR7","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.ijcard.2004.08.039","volume":"103","author":"K Nishio","year":"2005","unstructured":"Nishio K, Fukui T, Tsunoda F, Kawamura K, Itoh S, Konno N, Ozawa K, Katagiri T: Insulin resistance as a predictor for restenosis after coronary stenting. Int J Cardiol. 2005, 103: 128-134. 10.1016\/j.ijcard.2004.08.039.","journal-title":"Int J Cardiol"},{"key":"500_CR8","doi-asserted-by":"publisher","first-page":"e19228","DOI":"10.1371\/journal.pone.0019228","volume":"6","author":"A Song","year":"2011","unstructured":"Song A, Xu M, Bi Y, Xu Y, Huang Y, Li M, Wang T, Wu Y, Liu Y, Li X, Chen Y, Wang W, Ning G: Serum fetuin-A associated with type 2 diabetes and insulin resistance in Chinese adults. PLoS One. 2011, 6: e19228-10.1371\/journal.pone.0019228.","journal-title":"PLoS One"},{"key":"500_CR9","first-page":"125","volume":"23","author":"M Cirillo","year":"2010","unstructured":"Cirillo M: Evaluation of glomerular filtration rate and of albuminuria\/proteinuria. J Nephrol. 2010, 23: 125-132.","journal-title":"J Nephrol"},{"key":"500_CR10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","volume":"51","author":"GG Gensini","year":"1983","unstructured":"Gensini GG: A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983, 51: 606-10.1016\/S0002-9149(83)80105-2.","journal-title":"Am J Cardiol"},{"key":"500_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cca.2007.10.003","volume":"388","author":"KW Liang","year":"2008","unstructured":"Liang KW, Lee WJ, Lee WL, Chen YT, Ting CT, Sheu WH: Diabetes exacerbates angiographic coronary lesion progression in subjects with metabolic syndrome independent of CRP levels. Clin Chim Acta. 2008, 388: 41-45. 10.1016\/j.cca.2007.10.003.","journal-title":"Clin Chim Acta"},{"key":"500_CR12","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.jcma.2011.08.014","volume":"74","author":"HL Kuan","year":"2011","unstructured":"Kuan HL, The LL, Li CH, Hwu CM: Clinical and biochemical indicators of homeostasis model assessment-estimated insulin resistance in postmenopausal women. J Chin Med Assoc. 2011, 74: 442-447. 10.1016\/j.jcma.2011.08.014.","journal-title":"J Chin Med Assoc"},{"key":"500_CR13","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.2337\/diacare.25.7.1135","volume":"25","author":"E Bonora","year":"2002","unstructured":"Bonora E, Formentini G, Calcaterra F, Lombardi S, Marini F, Zenari L, Saggiani F, Poli M, Perbellini S, Raffaelli A, Cacciatori V, Santi L, Targher G, Bonadonna R, Muggeo M: HOMA-Estimated Insulin Resistance Is an Independent Predictor of Cardiovascular Disease in Type 2 Diabetic Subjects, Prospective data from the Verona Diabetes Complications Study. Diabetes Care. 2002, 25: 1135-1141. 10.2337\/diacare.25.7.1135.","journal-title":"Diabetes Care"},{"key":"500_CR14","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ecl.2008.06.001","volume":"37","author":"R Muniyappa","year":"2008","unstructured":"Muniyappa R, Iantorno M, Quon MJ: An Integrated View of Insulin Resistance and Endothelial Dysfunction. Endocrinol Metab Clin North Am. 2008, 37: 685-711. 10.1016\/j.ecl.2008.06.001.","journal-title":"Endocrinol Metab Clin North Am"},{"key":"500_CR15","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1016\/j.metabol.2006.05.008","volume":"55","author":"R Deepa","year":"2006","unstructured":"Deepa R, Velmurugan K, Arvind K, Sivaram P, Sientay C, Uday S, Mohan V: Serum levels of interleukin 6, C-reactive protein, vascular cell adhesion molecule 1, and monocyte chemotactic protein 1 in relation to insulin resistance and glucose intolerance\u2014the Chennai Urban Rural Epidemiology Study (CURES). Metabolism. 2006, 55: 1232-1238. 10.1016\/j.metabol.2006.05.008.","journal-title":"Metabolism"},{"key":"500_CR16","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1056\/NEJM199604113341504","volume":"334","author":"JP Despres","year":"1996","unstructured":"Despres JP, Lamarche B, Mauriege P, Cantin B, Dagenais GR, Moorjani S, Lupien PJ: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 1996, 334: 952-957. 10.1056\/NEJM199604113341504.","journal-title":"N Engl J Med"},{"key":"500_CR17","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jcmg.2007.09.003","volume":"1","author":"T Amano","year":"2008","unstructured":"Amano T, Matsubara T, Uetani T, Nanki M, Marui N, Kato M, Yoshida T, Arai K, Yokoi K, Ando H, Kumagai S, Ishii H, Izawa H, Hotta N, Murohara T: Abnormal glucose regulation is associated with lipid-rich coronary plaque: relationship to insulin resistance. JACC Cardiovasc Imaging. 2008, 1: 39-45. 10.1016\/j.jcmg.2007.09.003.","journal-title":"JACC Cardiovasc Imaging"},{"key":"500_CR18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1744-313X.2006.00622.x","volume":"33","author":"SP Marso","year":"2006","unstructured":"Marso SP, House JA, Hopkins PJ: Increase in interleukin-6 following arterial injury is related to insulin resistance, the \u2212174\u2009G\u2009\u2192\u2009C polymorphism and complex plaque morphology. Int J Immunogenet. 2006, 33: 347-354. 10.1111\/j.1744-313X.2006.00622.x.","journal-title":"Int J Immunogenet"},{"key":"500_CR19","doi-asserted-by":"publisher","first-page":"e4733","DOI":"10.1371\/journal.pone.0004733","volume":"4","author":"UC Broedl","year":"2009","unstructured":"Broedl UC, Lebherz C, Lehrke M, Stark R, Greif M, Becker A, von Ziegler F, Tittus J, Reiser M, Becker C, G\u00f6ke B, Parhofer KG, Leber AW: Low adiponectin levels are an independent predictor of mixed and non-calcified coronary atherosclerotic plaques. PLoS One. 2009, 4: e4733-10.1371\/journal.pone.0004733.","journal-title":"PLoS One"},{"key":"500_CR20","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1001\/jama.299.13.1561","volume":"299","author":"SE Nissen","year":"2008","unstructured":"Nissen SE, Nicholls SJ, Wolski K, Nesto R, Kupfer S, Perez A, Jure H, De Larochelli\u00e8re R, Staniloae CS, Mavromatis K, Saw J, Hu B, Lincoff AM, Tuzcu EM: Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes, The PERISCOPE randomized controlled trial. JAMA. 2008, 299: 1561-1573. 10.1001\/jama.299.13.1561.","journal-title":"JAMA"},{"key":"500_CR21","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1161\/01.CIR.94.6.1247","volume":"94","author":"R Hoffmann","year":"1996","unstructured":"Hoffmann R, Mintz GS, Dussaillant GR, Popma JJ, Pichard AD, Satler LF, Kent KM, Griffin J, Leon MB: Patterns and mechanism of in-stent restenosis, A serial intravascular ultrasound study. Circulation. 1996, 94: 1247-1254. 10.1161\/01.CIR.94.6.1247.","journal-title":"Circulation"},{"key":"500_CR22","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1111\/j.1755-5922.2010.00155.x","volume":"29","author":"MS Kim","year":"2011","unstructured":"Kim MS, Dean LS: Review: In-Stent Restenosis. Cardiovasc Ther. 2011, 29: 190-198. 10.1111\/j.1755-5922.2010.00155.x.","journal-title":"Cardiovasc Ther"},{"key":"500_CR23","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.2337\/dc08-9025","volume":"32","author":"DM Nathan","year":"2009","unstructured":"Nathan DM, Balkau B, Bonora E: The International Expert Committee: International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009, 32: 1327-1334.","journal-title":"Diabetes Care"},{"key":"500_CR24","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1475-2840-11-13","volume":"11","author":"RA Martins","year":"2012","unstructured":"Martins RA, Jones JG, Cumming SP, Silva MJ Coelho e, Teixeira AM, Ver\u00edssimo MT: Glycated hemoglobin and associated risk factors in older adults. Cardiovasc Diabetol. 2012, 11: 13-10.1186\/1475-2840-11-13.","journal-title":"Cardiovasc Diabetol"},{"key":"500_CR25","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1475-2840-10-98","volume":"10","author":"Y Liu","year":"2011","unstructured":"Liu Y, Yang YM, Zhu J, Tan HQ, Liang Y, Li JD: Prognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease, A systematic review and meta-analysis. Cardiovasc Diabetol. 2011, 10: 98-10.1186\/1475-2840-10-98.","journal-title":"Cardiovasc Diabetol"},{"key":"500_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1159\/000314331","volume":"116","author":"H Ueda","year":"2010","unstructured":"Ueda H, Mitsusada N, Harimoto K, Miyawaki M, Yasuga Y, Hiraoka H: Glycosylated hemoglobin is a predictor of major adverse cardiac events after drug-eluting stent implantation in patients with diabetes mellitus. Cardiology. 2010, 116: 51-57. 10.1159\/000314331.","journal-title":"Cardiology"},{"key":"500_CR27","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/bmj.322.7277.15","volume":"322","author":"KT Khaw","year":"2001","unstructured":"Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N: Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ. 2001, 322: 15-18. 10.1136\/bmj.322.7277.15.","journal-title":"BMJ"},{"key":"500_CR28","doi-asserted-by":"publisher","first-page":"413","DOI":"10.7326\/0003-4819-141-6-200409210-00006","volume":"141","author":"KT Khaw","year":"2004","unstructured":"Khaw KT, Wareham N, Bingham S, Luben R, Welch A, Day N: Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk. Ann Intern Med. 2004, 141: 413-420.","journal-title":"Ann Intern Med"},{"key":"500_CR29","doi-asserted-by":"publisher","first-page":"1699","DOI":"10.1001\/archinte.168.15.1699","volume":"168","author":"HC Gerstein","year":"2008","unstructured":"Gerstein HC, Swedberg K, Carlsson J, CHARM Program Investigators: The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Arch Intern Med. 2008, 168: 1699-1704. 10.1001\/archinte.168.15.1699.","journal-title":"Arch Intern Med"},{"key":"500_CR30","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1046\/j.1464-5491.2002.00835.x","volume":"19","author":"N Unwin","year":"2002","unstructured":"Unwin N, Shaw J, Zimmet P, Alberti KG: Impaired fasting glycemia: the current definition and intervention. Diabet Med. 2002, 19: 708-723.","journal-title":"Diabet Med"},{"key":"500_CR31","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1743-7075-7-26","volume":"7","author":"A Esteghamati","year":"2010","unstructured":"Esteghamati A, Ashraf H, Khalilzadeh O, Zandieh A, Nakhjavani M, Rashidi A, Haghazali M, Asgari F: Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007). Nutr Metab (Lond). 2010, 7: 26-10.1186\/1743-7075-7-26.","journal-title":"Nutr Metab (Lond)"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1475-2840-11-71.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T19:41:42Z","timestamp":1630525302000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/1475-2840-11-71"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6,18]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["500"],"URL":"https:\/\/doi.org\/10.1186\/1475-2840-11-71","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,6,18]]},"assertion":[{"value":"28 April 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"71"}}